DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,511,986 | +5.2% | 1,227,376 | +1.7% | 1.97% | +7.5% |
| Q2 2023 | $289,517,040 | +4.0% | 1,206,321 | +9.2% | 1.84% | +8.3% |
| Q1 2023 | $278,501,428 | +109.3% | 1,104,989 | +117.8% | 1.70% | +91.6% |
| Q4 2022 | $133,059,800 | -46.8% | 507,339 | -47.6% | 0.88% | -50.3% |
| Q3 2022 | $250,310,000 | -8.4% | 969,105 | -10.1% | 1.78% | +5.7% |
| Q2 2022 | $273,235,000 | -20.3% | 1,077,764 | -7.8% | 1.68% | -9.5% |
| Q1 2022 | $342,736,000 | +870.6% | 1,168,431 | +916.7% | 1.86% | +917.5% |
| Q4 2021 | $35,313,000 | -4.4% | 114,929 | -5.3% | 0.18% | -22.8% |
| Q3 2021 | $36,947,000 | +75.2% | 121,359 | +54.4% | 0.24% | +61.2% |
| Q2 2021 | $21,094,000 | +24.0% | 78,603 | +4.0% | 0.15% | +10.5% |
| Q1 2021 | $17,006,000 | -71.5% | 75,554 | -71.8% | 0.13% | -70.2% |
| Q4 2020 | $59,568,000 | -29.6% | 268,156 | -31.8% | 0.45% | -38.1% |
| Q3 2020 | $84,617,000 | +68.1% | 392,962 | +38.0% | 0.72% | +48.0% |
| Q2 2020 | $50,340,000 | – | 284,679 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |